MET
38
-6
DOW
43
-4
BAC
41
2
UPS
41
-2
DGX
36
-3
DO
62
-7
HD
29
-8
UNH
48
2
MAR
57
-2
VIX
71
-3
SBUX
45
2
AAL
30
6
PCAR
59
-2
CHRW
36
2
DG
30
2
NVDA
52
-4
MTB
48
3
RCL
58
3
ORCL
59
-3
AMAT
58
-3
MET
38
-6
DOW
43
-4
BAC
41
2
UPS
41
-2
DGX
36
-3
DO
62
-7
HD
29
-8
UNH
48
2
MAR
57
-2
VIX
71
-3
SBUX
45
2
AAL
30
6
PCAR
59
-2
CHRW
36
2
DG
30
2
NVDA
52
-4
MTB
48
3
RCL
58
3
ORCL
59
-3
AMAT
58
-3
Financhill
Back

Astria Therapeutics Quote, Financials, Valuation and Earnings

The little-known AI stock you need to read about now...

Get the name - FREE.
Sell
22

ATXS
Astria Therapeutics

Last Price:
10.53
Seasonality Move:
-19.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Will Crypto Make People Rich Again Starting April 2024?

Details on how to profit here.

Astria Therapeutics Price Quote

$10.53
-0.02 (-0.19%)
(Updated: April 18, 2024 at 6:55 PM ET)

Astria Therapeutics Key Stats

Sell
22
Astria Therapeutics (ATXS) is a Sell
Day range:
$10.46 - $11.29
52-week range:
$4.26 - $16.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.92%
Volume:
439.8K
Avg. volume:
1.3M
1-year change:
-2.5%
Market cap:
$578.7M
Revenue:
$0
EPS:
$-2.42

How Much Does Astria Therapeutics Make?

Data Unavailable

Is Astria Therapeutics Growing As A Company?

Data Unavailable

Astria Therapeutics Stock Price Performance

What Is Astria Therapeutics 52-Week High & Low?

Astria Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Astria Therapeutics?

Is Astria Therapeutics Cash Flow Positive?

  • What Is ATXS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$68.4M
  • What Is Astria Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $88.4M
  • What Is Astria Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $135.1M

Astria Therapeutics Return On Invested Capital

Data Unavailable

Astria Therapeutics Earnings Date & Stock Price

Astria Therapeutics Competitors

  • Who Are Astria Therapeutics's Competitors?
    Below is a list of companies who compete with Astria Therapeutics or are related in some way:
    • Ampio Pharmaceuticals Inc (AMPE)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Astria Therapeutics Dividend Yield

Data Unavailable

Astria Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 25.57
Upside from Last Price: 142.38%

Major Shareholders

  • How many ATXS shares are owned by institutional investors?
    56.6M ATXS shares are owned by institutional investors
  • How many ATXS shares are owned by insiders?
    767.8K ATXS shares are owned by insiders